Vector Bioscience

Health Care · Biologics & Biosimilars

Overview

The most versatile targeted delivery. Deploying breakthrough research from Cambridge to tangible applications.

Funding and backers

Backers
1
Cambridge Enterprise
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Navigator MedicinesVenture round $10M · 1 mo ago · Founded 2024
Leading the advancement of biologics for targeted immune regulation & restoration.
Paradigm Shift for Parkinson’s.. Cellestial Health is a preclinical biopharmaceutical company transforming the future of brain disease…
AI for prediction in neurological and psychiatric conditions. Brain Health AI prediction that is clinically validated, explainable, and…
ImmunaiSeries B $215M · 5 yr ago · 201-500 employees · 10 roles
We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
AttralusVenture round $56M · 2 yr ago · Founded 2019
Attralus is focused on advancing new solutions for amyloidosis therapy. The team has deep experience in Amyloid research and therapeutic…
Cisterna BiologicsFounded 2025 · 11-50 employees
High-purity RNA for research and development. Cisterna Biologics offers custom RNA synthesis, including mRNA, with fast turnaround and…

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
121 portfolio companies: Xampla, xWatts, Hereda and 118 more